| Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™ (NCT01196026) | GlaxoSmithKline | 2010-09-15 |
| T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010 (NCT03022396) | Stanford University | 2010-09-01 |
| B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) (NCT03020498) | Stanford University | 2010-09-01 |
| Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications (NCT01227967) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 (NCT01224262) | Liquidia Technologies, Inc. | 2010-09-01 |
| Immunogenicity and Safety of V70P5 Revaccination Subjects (NCT01210898) | Novartis Vaccines | 2010-09-01 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine (NCT01265914) | Immune Targeting Systems Ltd | 2010-08-01 |
| Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM (NCT01160237) | GlaxoSmithKline | 2010-08-01 |
| Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants (NCT01194297) | University of Rochester | 2010-08-01 |
| Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects (NCT01162122) | Novartis Vaccines | 2010-08-01 |
| Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011 (NCT01140009) | University of British Columbia | 2010-08-01 |
| Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners (NCT01207518) | Ottawa Hospital Research Institute | 2010-08-01 |
| Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups (NCT01654809) | Beijing Center for Disease Control and Prevention | 2010-08-01 |
| Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects (NCT01356316) | Adimmune Corporation | 2010-08-01 |
| Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu (NCT01158326) | Hospital de Clinicas de Porto Alegre | 2010-08-01 |
| Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years (NCT01153685) | GlaxoSmithKline | 2010-07-09 |
| Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old (NCT01356342) | Adimmune Corporation | 2010-07-01 |
| 2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies (NCT01270685) | US Department of Veterans Affairs | 2010-07-01 |
| Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old (NCT01161160) | GlaxoSmithKline | 2010-07-01 |
| Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001) (NCT01146119) | BiondVax Pharmaceuticals ltd. | 2010-07-01 |
| Yearly Strain Variation Study, 2010/2011 (NCT01157702) | Alachua Government Services, Inc. | 2010-07-01 |
| Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults (NCT01172054) | VaxInnate Corporation | 2010-07-01 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults (NCT01144299) | GlaxoSmithKline | 2010-06-17 |
| Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (NCT01147068) | Protein Sciences Corporation | 2010-06-01 |
| A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere (NCT01306305) | Crucell Holland BV | 2010-06-01 |
| Seasonal Influenza Vaccine Effectiveness Study in Kenya (NCT01432340) | Gideon Emukule | 2010-06-01 |
| Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 (NCT00912496) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations (NCT01146912) | Columbia University | 2010-06-01 |
| Influenza Vaccine Challenge Study in Healthy Subjects (NCT01226758) | PepTcell Limited | 2010-06-01 |
| Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route) (NCT01138397) | Sanofi Pasteur, a Sanofi Company | 2010-06-01 |
| Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation (NCT01130636) | Pharmahungary Group | 2010-06-01 |
| Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season (NCT01146015) | Abbott Biologicals | 2010-06-01 |
| Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1 (NCT00989274) | Instituto Nacional de Salud Publica, Mexico | 2010-06-01 |
| Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older (NCT01114620) | GlaxoSmithKline | 2010-05-17 |
| A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population (NCT01113580) | Seqirus | 2010-05-01 |
| Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route) (NCT01121822) | Sanofi Pasteur, a Sanofi Company | 2010-05-01 |
| A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine (NCT00866580) | GlaxoSmithKline | 2010-05-01 |
| Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children (NCT01096056) | GlaxoSmithKline | 2010-04-05 |
| Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults (NCT01008956) | GlaxoSmithKline | 2010-04-01 |
| PRIMAGE (Probiotics, Immunity and Ageing) (NCT01066377) | University of Reading | 2010-04-01 |
| The Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER Study (NCT01106196) | University College, London | 2010-04-01 |
| Phase 1b Influenza Vaccine Study in Healthy Subjects (NCT01181336) | PepTcell Limited | 2010-04-01 |
| Collection and Extraction of Respiratory Specimens (NCT01083511) | QIAGEN Gaithersburg, Inc | 2010-03-01 |
| Rapid Diagnostic Test for Influenza (NCT01089816) | Meso Scale Diagnostics, LLC. | 2010-03-01 |
| Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu) (NCT01069874) | Barts & The London NHS Trust | 2010-03-01 |
| Follow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 Months (NCT01096238) | National Taiwan University Hospital | 2010-03-01 |
| Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age (NCT01037634) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-03-01 |
| A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults (NCT01089660) | Sanofi Pasteur, a Sanofi Company | 2010-03-01 |
| Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age (NCT01051661) | GlaxoSmithKline | 2010-02-12 |
| Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults (NCT01059617) | GlaxoSmithKline | 2010-02-09 |
| TIV Infant/Toddler Response Evaluation (TITRE)- Follow-up & Focus on Influenza B (NCT01067404) | British Columbia Centre for Disease Control | 2010-02-01 |
| Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy (NCT01146353) | Midwestern University | 2010-02-01 |
| Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine (NCT01063088) | Alachua Government Services, Inc. | 2010-02-01 |
| Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers (NCT01389466) | Green Cross Corporation | 2010-02-01 |
| Drug Use Investigation for Arepanrix® (H1N1) (NCT02069496) | GlaxoSmithKline | 2010-02-01 |
| Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza (NCT01068912) | MDVI, LLC | 2010-02-01 |
| Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy Volunteers (NCT01026350) | Hadassah Medical Organization | 2010-01-01 |
| Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study (NCT01037829) | Novartis Vaccines | 2010-01-01 |
| Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines (NCT01111968) | Butantan Institute | 2010-01-01 |
| Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine (NCT00999206) | Abbott Biologicals | 2010-01-01 |
| A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza (NCT01050257) | Hoffmann-La Roche | 2010-01-01 |
| Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza (NCT01056380) | Romark Laboratories L.C. | 2010-01-01 |
| Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India (NCT01053143) | Sanofi Pasteur, a Sanofi Company | 2010-01-01 |
| A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza (NCT01052961) | Chinese University of Hong Kong | 2010-01-01 |
| Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants (NCT01047202) | Sinovac Biotech Co., Ltd | 2009-12-01 |
| FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record (NCT01146899) | Columbia University | 2009-12-01 |
| Mechanisms of Severe Acute Influenza Consortium (MOSAIC) (NCT00965354) | Imperial College London | 2009-12-01 |
| Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults (NCT01032980) | Sanofi Pasteur, a Sanofi Company | 2009-12-01 |
| Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children (NCT01014091) | GlaxoSmithKline | 2009-12-01 |
| Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients (NCT01039220) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-12-01 |
| Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month (NCT01040078) | Centers for Disease Control and Prevention, China | 2009-12-01 |
| Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza (NCT01037205) | Ansun Biopharma, Inc. | 2009-12-01 |
| Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants (NCT01494740) | Shanghai Institute Of Biological Products | 2009-12-01 |
| Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects (NCT01079273) | Opera CRO, a TIGERMED Group Company | 2009-12-01 |
| A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes (NCT01053377) | National Institute for Public Health and the Environment (RIVM) | 2009-12-01 |
| Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children (NCT01003418) | GlaxoSmithKline | 2009-11-17 |
| Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older (NCT00979602) | GlaxoSmithKline | 2009-11-09 |
| Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus (NCT01023711) | University of Rochester | 2009-11-01 |
| H1N1 Vaccine at Two Dose Levels in HIV Positive Adults (NCT00992433) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Acute Respiratory Infection Consortium (NCT01021098) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2009-11-01 |
| Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus (NCT01044095) | Armed Forces Research Institute of Medical Sciences, Thailand | 2009-11-01 |
| Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine (NCT01000584) | David Scheifele | 2009-11-01 |
| The Chloroquine for Influenza Prevention Trial (NCT01078779) | National University Hospital, Singapore | 2009-11-01 |
| Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults (NCT01014806) | Novavax | 2009-11-01 |
| Vaccination Against Influenza H1N1 in Rheumatic Diseases (NCT01006681) | Tel-Aviv Sourasky Medical Center | 2009-11-01 |
| Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children (NCT01000831) | University of British Columbia | 2009-11-01 |
| A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain (NCT01032837) | Hoffmann-La Roche | 2009-11-01 |
| Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine (NCT01023776) | University of Rochester | 2009-11-01 |
| Novartis H1N1 Vaccine in Pregnant Women (NCT00992719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine (NCT00950456) | Alachua Government Services, Inc. | 2009-11-01 |
| Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women (NCT01024400) | Institut National de la Santé Et de la Recherche Médicale, France | 2009-11-01 |
| Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom (NCT00996853) | GlaxoSmithKline | 2009-10-31 |
| Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age (NCT00976820) | GlaxoSmithKline | 2009-10-20 |
| Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1) (NCT01024673) | University of Pittsburgh | 2009-10-15 |
| Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People (NCT00992784) | GlaxoSmithKline | 2009-10-15 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes (NCT00992511) | GlaxoSmithKline | 2009-10-14 |
| Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children (NCT00980005) | GlaxoSmithKline | 2009-10-13 |
| Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1) (NCT00979407) | GlaxoSmithKline | 2009-10-12 |
| Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older (NCT00985088) | GlaxoSmithKline | 2009-10-11 |
| Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children (NCT00985790) | GlaxoSmithKline | 2009-10-08 |